China A-shares opened lower and weakened into the midday session; ChiNext Index fell 4.32% at the break, Shenzhen Composite down 3.37% and Shanghai Composite down 1.74%. Market breadth was weak with more than 4,800 stocks down and half-day turnover above 1.1 trillion yuan. Power stocks outperformed, Zhejiang Xinneng hit the daily limit. Autos strengthened, with JAC Motors and Zotye Auto hitting daily limits. Cybersecurity names moved higher, Yongxin Zhicheng and Zhongxin Saike hit limits. Pork-r

2026-09-28

China A-shares opened lower and weakened into the midday session; ChiNext Index fell 4.32% at the break, Shenzhen Composite down 3.37% and Shanghai Composite down 1.74%. Market breadth was weak with more than 4,800 stocks down and half-day turnover above 1.1 trillion yuan. Power stocks outperformed, Zhejiang Xinneng hit the daily limit. Autos strengthened, with JAC Motors and Zotye Auto hitting daily limits. Cybersecurity names moved higher, Yongxin Zhicheng and Zhongxin Saike hit limits. Pork-related shares saw localized gains, Dongrui hit the limit. CPO-related names plunged, Xiangtong Optoelectronics and FiberHome hit limit-down. Telecom equipment, electronic components, semiconductors and non-ferrous metals were among the worst-performing sectors.

其他消息
2026-09-27

Overview: China A-share exchanges (Shanghai, Shenzhen, Beijing) and domestic futures markets will be closed Oct.1–7 for National Day; Hong Kong Stock Exchange closed Oct.1 with north/southbound trading suspended; Taiwan market closed Monday; India NSE closed Friday. Major market drivers next week include US nonfarm payrolls and core PCE, a packed Fed speaker schedule, the RBA rate decision and an OPEC+ meeting Sunday. Monday: Dallas Fed business index; ECB president Lagarde testifies to European

2026-09-28

Zhongke Yuhang and Guangzhou Laboratory are jointly developing a space-pharmaceutical payload and plan to run scenario validation. The first payload is scheduled for suborbital flight on the Lihong-2 reusable launcher in Q1 2027 to conduct protein and small-molecule drug crystallization experiments and to perform preliminary technology validation of space-pharmaceutical equipment.